Literature DB >> 10644308

Immunohistochemical analysis of the distribution of measles related antigen in the intestinal mucosa in inflammatory bowel disease.

M Iizuka1, M Chiba, M Yukawa, T Nakagomi, T Fukushima, S Watanabe, O Nakagomi.   

Abstract

BACKGROUND: Measles virus is implicated in the aetiology of Crohn's disease. This measles hypothesis is mainly supported by immunohistochemical findings that the measles related antigen is present in the intestine of patients with Crohn's disease. Recently we isolated this antigen from the intestine of a patient with Crohn's disease using a molecular cloning technique and produced the monoclonal antibody against it (designated 4F12). AIM: To discover whether the measles related antigen is uniquely present in Crohn's disease. SUBJECTS/
METHODS: Colonic mucosa samples from 20 patients with Crohn's disease, 20 with ulcerative colitis, 11 with non-inflammatory bowel disease (IBD) colitis, and nine controls were immunohistochemically stained with the anti-measles monoclonal antibody 4F12. The numbers of positive cells, the ratio of positive cells to nucleated cells, and the staining intensity of the positive cells were compared. Furthermore, the distribution of the measles antigen in other human organs was examined.
RESULTS: Both the number of positive cells and the ratio of positive cells to nucleated cells were significantly increased in Crohn's disease, ulcerative colitis, and non-IBD colitis compared with controls (p<0.05) but were similar among the three disease groups. The staining intensity of the positive cells was also similar among the three disease groups. Small numbers of positive cells were observed in the oesophagus, stomach, duodenum, jejunum, and lung.
CONCLUSIONS: The presence of the measles related antigen in the colonic mucosa was not unique to Crohn's disease. These results, together with the observation that such a measles related antigen was derived from host protein, do not support the hypothesis that measles virus causes Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644308      PMCID: PMC1727809          DOI: 10.1136/gut.46.2.163

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  31 in total

1.  Measles virus and Crohn's disease: view of a medical virologist.

Authors:  V ter Meulen
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

2.  Dendritic cells and scavenger macrophages in chronic inflammatory bowel disease.

Authors:  C A Seldenrijk; H A Drexhage; S G Meuwissen; S T Pals; C J Meijer
Journal:  Gut       Date:  1989-04       Impact factor: 23.059

3.  Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues.

Authors:  J Srinivasappa; J Saegusa; B S Prabhakar; M K Gentry; M J Buchmeier; T J Wiktor; H Koprowski; M B Oldstone; A L Notkins
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Simultaneous localization of multiple tissue antigens using the peroxidase-labeled antibody method: a study on pituitary glands of the rat.

Authors:  P K Nakane
Journal:  J Histochem Cytochem       Date:  1968-09       Impact factor: 2.479

6.  Measles virus and Crohn's disease.

Authors:  J Hermon-Taylor; J Ford; N Sumar; D Millar; T Doran; M Tizard
Journal:  Lancet       Date:  1995-04-08       Impact factor: 79.321

7.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

8.  Lymphoid cell subsets in colonic mucosa and HLA-DR antigens on colonic epithelia in colitis excluding ulcerative colitis and Crohn's disease.

Authors:  M Iizuka; M Chiba; Y Horie; O Masamune; H Ohta
Journal:  Gastroenterol Jpn       Date:  1990-12

9.  Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments.

Authors:  R S Fujinami; M B Oldstone; Z Wroblewska; M E Frankel; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

10.  Involvement of the chaperonin dnaK in the rapid degradation of a mutant protein in Escherichia coli.

Authors:  A L Goldberg
Journal:  EMBO J       Date:  1992-01       Impact factor: 11.598

View more
  7 in total

1.  No evidence of persistent mumps virus infection in inflammatory bowel disease.

Authors:  M Iizuka; H Saito; M Yukawa; H Itou; T Shirasaka; M Chiba; T Fukushima; S Watanabe
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

Review 2.  Clinical aspects and pathophysiology of inflammatory bowel disease.

Authors:  Barbara A Hendrickson; Ranjana Gokhale; Judy H Cho
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 3.  Detection of persistent measles virus infection in Crohn's disease: current status of experimental work.

Authors:  S Ghosh; E Armitage; D Wilson; P D Minor; M A Afzal
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

Review 4.  MMR: where are we now?

Authors:  David Elliman; Helen Bedford
Journal:  Arch Dis Child       Date:  2007-07-11       Impact factor: 3.791

Review 5.  Measles vaccination and inflammatory bowel disease: controversy laid to rest?

Authors:  R L Davis; K Bohlke
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

6.  Molecular mimicry, inflammatory bowel disease, and the vaccine safety debate.

Authors:  Susy Yusung; Jonathan Braun
Journal:  BMC Med       Date:  2014-09-18       Impact factor: 8.775

7.  Bioinformatic and immunological analysis reveals lack of support for measles virus related mimicry in Crohn's disease.

Authors:  Dimitrios Polymeros; Zacharias P Tsiamoulos; Andreas L Koutsoumpas; Daniel S Smyk; Maria G Mytilinaiou; Konstantinos Triantafyllou; Dimitrios P Bogdanos; Spiros D Ladas
Journal:  BMC Med       Date:  2014-08-28       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.